Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.

MLA

Hariharan, Ananya, et al. “Heterogeneous RNA Editing and Influence of ADAR2 on Mesothelioma Chemoresistance and the Tumor Microenvironment.” Molecular Oncology, vol. 16, no. 22, Dec. 2022, pp. 3949–74. EBSCOhost, https://doi.org/10.1002/1878-0261.13322.

APA

Hariharan, A., Qi, W., Rehrauer, H., Wu, L., Ronner, M., Wipplinger, M., Kresoja-Rakic, J., Sun, S., Oton-Gonzalez, L., Sculco, M., Serre-Beinier, V., Meiller, C., Blanquart, C., Fonteneau, J.-F., Vrugt, B., Rüschoff, J. H., Opitz, I., Jean, D., de Perrot, M., & Felley-Bosco, E. (2022). Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment. Molecular Oncology, 16(22), 3949–3974. https://doi.org/10.1002/1878-0261.13322

Chicago

Hariharan, Ananya, Weihong Qi, Hubert Rehrauer, Licun Wu, Manuel Ronner, Martin Wipplinger, Jelena Kresoja-Rakic, et al. 2022. “Heterogeneous RNA Editing and Influence of ADAR2 on Mesothelioma Chemoresistance and the Tumor Microenvironment.” Molecular Oncology 16 (22): 3949–74. doi:10.1002/1878-0261.13322.